Breadth of coverage is the distinguishing factor of our Healthcare research effort.  By collectively developing detailed expertise for most facets of the industry, our team is better able to identify and quantify for our clients what they believe are the best investments in this dynamic industry.  A recent example of our broad equity research offering in this area is our quarterly Drug Channel Monitor, a collaborative effort between several of our analysts to examine key trends for pharmaceutical manufacturers, drug distributors, pharma service providers, and drug stores.  Access to our Healthcare equity research is available on this website for institutional clients of Raymond James & Associates - please contact us for more information about becoming a client of Raymond James.